. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitorsDrug ApprovalEnzyme Inhibitors/therapeutic useErectile Dysfunction/drug therapyHumansMalePiperazines/therapeutic usePurinesSildenafil CitrateSulfonesUnited StatesUnited States Food and Drug Administration
Substances: See more » Enzyme InhibitorsPiperazinesPurinesSulfonesSildenafil Citrate3',5'-Cyclic-GMP Phosphodiesterases
Year: 1998 PMID: 9606444 DOI: 10.1093/ajhp/55.10.981a
Source DB: PubMed Journal: Am J Health Syst Pharm ISSN: 1079-2082 Impact factor: 2.637